Non-compliance with oral chemotherapy in childhood leukaemia.
about
Attitude of health-care providers toward childhood leukemia patients with different socio-economic status.Recent advances in management of acute leukaemia.Ulcerative colitis in a Nigerian girl: a case report.Recent advances in the pharmacogenomics of thiopurine methyltransferase.Health-care providers' perspectives on childhood cancer treatment in Manado, Indonesia.A grounded theory of the process of adherence to oral chemotherapy in Hispanic and caucasian children and adolescents with acute lymphoblastic leukemiaLicensing and labelling of drugs in a paediatric oncology ward.Profile of non-compliance in lymphoblastic leukaemia.Clinical and laboratory evaluation of compliance in acute lymphoblastic leukaemia.Medical and psychosocial associates of nonadherence in adolescents with cancer.A literature review to identify interventions to improve the use of medicines in children.Liquid growth hormone: preservatives and buffers.Analysis of outcomes in adolescents and young adults with chronic myelogenous leukemia treated with upfront tyrosine kinase inhibitor therapy.Rethinking Adherence: A Proposal for a New Approach to Risk Assessment.Current issues in pediatric medication adherence.2013 updated American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards including standards for the safe administration and management of oral chemotherapyOptimal therapy for acute lymphoblastic leukemia in adolescents and young adults.Cancer in Australian Aboriginal children: room for improvement.Towards understanding problems in the parent-practitioner relationship when a child has cancer: meta-synthesis of the qualitative literature.A comparison of red blood cell thiopurine metabolites in children with acute lymphoblastic leukemia who received oral mercaptopurine twice daily or once daily: a Pediatric Oncology Group study (now The Children's Oncology Group).Random serum methotrexate determinations for assessing compliance with maintenance therapy for childhood acute lymphoblastic leukemia.Gender, adolescence and the management of diabetes.
P2860
Q33293111-06DACE06-9491-42B7-BCE5-850C46208C47Q33930802-B072365B-F058-448D-BD41-92A1A5C2BFB1Q34439031-904B300A-5C98-4842-8E73-DA09FE9BBBBAQ34574036-2FB68FFA-DE04-42B6-A2C5-A6883163CBF8Q34736906-23B6DC8B-1E46-41A3-A06F-7F2213FFB20DQ35091199-797F96CA-10AD-4EAB-86B0-9E4B398A71EEQ35219672-6E392D66-0B04-45DC-874C-2BA86C40CAE3Q35254934-0E74F0CC-75D5-4FF1-B773-F9FEA4CB22DAQ35280135-BCCC0B23-CBF0-4496-92C9-4202E78E20E9Q35540284-E329C923-FD9F-4586-ADF6-B5ED8D88B0DDQ35939853-4568C853-BBB2-44A2-B50C-99036C37EC0EQ35946626-0F1D38ED-3488-461E-8F99-67F5C803AFE8Q36094702-C0E2A9B3-43C7-4A33-A6BB-F7B589ABE7BBQ36933578-A2E20C82-2B07-42E2-90FA-1F8268942A3DQ36967201-BEE6798F-F4CD-435D-8994-1946D3FFB158Q37063671-1406A170-F4F8-4B76-AD5E-A33B8F5A405AQ37883008-307247CC-2B23-4B4B-9DFE-84F8F76020A2Q38063923-ECE8C20C-67C2-4B0B-BF87-BA002DFA3725Q38799327-0061834C-F657-4DC3-9C41-B61429528904Q42630783-95DF9657-53A6-43E6-B6B9-8BABD49C8E91Q43254049-7CCFCF34-EDB7-41EB-A04C-C73728EFB4D8Q50141835-139D35AE-E914-4196-816F-20DFC6E173A3
P2860
Non-compliance with oral chemotherapy in childhood leukaemia.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Non-compliance with oral chemotherapy in childhood leukaemia.
@en
Non-compliance with oral chemotherapy in childhood leukaemia.
@nl
type
label
Non-compliance with oral chemotherapy in childhood leukaemia.
@en
Non-compliance with oral chemotherapy in childhood leukaemia.
@nl
prefLabel
Non-compliance with oral chemotherapy in childhood leukaemia.
@en
Non-compliance with oral chemotherapy in childhood leukaemia.
@nl
P2860
P1433
P1476
Non-compliance with oral chemotherapy in childhood leukaemia.
@en
P2093
Lilleyman JS
P2860
P304
P356
10.1136/BMJ.313.7067.1219
P407
P577
1996-11-01T00:00:00Z